Menu

ADARx Pharmaceuticals, Inc. ADRX

Full chart Compare
Set alert

Price alert · ADRX

All alert types
13.23 USD -0.06 (-0.45%)

At closeNov 6, 2026, 4:00 PM EST

13.23 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

12.50 Day range 13.73
13.23 52-week range 20.64
YTD
-31.63%
1 year
-31.63%

Revenue & Expenses

Other Income → Expenses: $15.28MExpenses → Selling, General & Admin: $20.30MExpenses → Research & Development: $71.51MGross Profit → Expenses: $3.45MRevenue → Gross Profit: $3.45MNet Loss → Expenses: $73.09MOther Income$15.28MGross Profit$3.45MNet Loss$73.09MExpenses$91.81MSelling, General & Admin$20.30MResearch & Development$71.51MRevenue$3.45M

Latest period ending Dec 31, 2025 · select a line to chart its full history

ADRX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2005 Dec 31, 2005FY 2004 Dec 31, 2004FY 2003 Dec 31, 2003
3.45M01.04B1.15B1.05B
3.45M0260.81M346.11M342.13M
-88.36M-58.23M9.57M88.06M67.87M
-73.09M-46.36M62.47M65.66M48.18M
-6.43-4.220.850.890.66
ADRX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2005 Dec 31, 2005FY 2004 Dec 31, 2004FY 2003 Dec 31, 2003
66.52M14.03M34.07M42.29M67.50M
507.65M233.45M1.17B970.61M958.45M
352.29M12.98M390.00M271.85M335.55M
7.74M4.33M000
-202.25M-137.15M776.91M698.76M622.90M
ADRX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2005 Dec 31, 2005FY 2004 Dec 31, 2004FY 2003 Dec 31, 2003
262.29M-48.56M124.72M87.86M143.20M
-209.93M39.51M-137.61M-119.67M-105.92M
97.00K225.00K4.67M6.60M3.75M
-2.94M-455.00K-28.99M-88.28M-39.45M
52.48M-8.82M-8.22M-25.21M41.03M